128 related articles for article (PubMed ID: 12752158)
1. Topical tacrolimus (FK506) for relapsing erosive stomatitis in paraneoplastic pemphigus.
Vecchietti G; Kerl K; Hügli A; Samson J; Borradori L
Br J Dermatol; 2003 Apr; 148(4):833-4. PubMed ID: 12752158
[No Abstract] [Full Text] [Related]
2. Paraneoplastic Pemphigus. A Life-Threatening Autoimmune Blistering Disease.
Tirado-Sánchez A; Bonifaz A
Actas Dermosifiliogr; 2017 Dec; 108(10):902-910. PubMed ID: 28801011
[TBL] [Abstract][Full Text] [Related]
3. Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome).
Frew JW; Murrell DF
Dermatol Clin; 2011 Oct; 29(4):607-12. PubMed ID: 21925005
[TBL] [Abstract][Full Text] [Related]
4. Metastatic prostate cancer presenting as paraneoplastic pemphigus: a favourable clinical response to combined androgen blockade and conventional immunosuppressive therapy.
Mignogna MD; Fortuna G; Leuci S; Adamo D; Ruoppo E
Br J Dermatol; 2009 Feb; 160(2):468-70. PubMed ID: 19120335
[No Abstract] [Full Text] [Related]
5. Prolonged mucosal topical application of cyclosporin A for severe stomatitis of paraneoplastic pemphigus.
Hashimoto K; Kobayashi K; Nakamura Y; Yukino Y; Tsuji G; Kim H; Kataoka K; Amagai M
Australas J Dermatol; 2023 Aug; 64(3):439-441. PubMed ID: 37409358
[No Abstract] [Full Text] [Related]
6. Beneficial effects of topical tacrolimus on recalcitrant erosions of pemphigus vulgaris.
Gach JE; Ilchyshyn A
Clin Exp Dermatol; 2004 May; 29(3):271-2. PubMed ID: 15115509
[TBL] [Abstract][Full Text] [Related]
7. A Novel Use of Topical Ketamine for the Treatment of Oral Pemphigus: A Case Report.
Higgins EA; West JA
J Palliat Care; 2021 Jul; 36(3):146-147. PubMed ID: 32713289
[TBL] [Abstract][Full Text] [Related]
8. [Important systemic absorption of topical tacrolimus during treatment of severe pemphigus vulgaris].
Skowron F; Dalle S; Marcilly MC; Balme B; Thomas L
Ann Dermatol Venereol; 2005 Mar; 132(3):264-5. PubMed ID: 15924053
[No Abstract] [Full Text] [Related]
9. Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus.
Williams JV; Marks JG; Billingsley EM
Br J Dermatol; 2000 Mar; 142(3):506-8. PubMed ID: 10735959
[TBL] [Abstract][Full Text] [Related]
10. Topical 0.03% tacrolimus for treatment of pemphigus erythematosus in a Korea Jindo dog.
Bhang DH; Choi US; Jung YC; Kim MK; Choi EW; Seo KW; Kang MS; Hwang CY; Kim DY; Youn HY; Lee CW
J Vet Med Sci; 2008 Apr; 70(4):415-7. PubMed ID: 18460840
[TBL] [Abstract][Full Text] [Related]
11. Topical tacrolimus (protopic) for the treatment of a localized pemphigus foliaceus.
Termeer CC; Technau K; Augustin M; Simon JC
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):636-7. PubMed ID: 15324416
[No Abstract] [Full Text] [Related]
12. Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment.
Hall VC; Liesegang TJ; Kostick DA; Lookingbill DP
Arch Dermatol; 2003 Aug; 139(8):1083-4. PubMed ID: 12925404
[No Abstract] [Full Text] [Related]
13. Equal efficacy of topical tacrolimus and clobetasone butyrate in pemphigus foliaceus.
Cohen SN; Lim RP; Paul CJ; Abdullah A
Int J Dermatol; 2006 Nov; 45(11):1379. PubMed ID: 17076736
[No Abstract] [Full Text] [Related]
14. Recalcitrant pemphigus vulgaris responding to systemic tacrolimus.
Büsing V; Kern JS; Bruckner-Tuderman L; Hofmann SC
Dermatology; 2010; 221(2):122-6. PubMed ID: 20587990
[TBL] [Abstract][Full Text] [Related]
15. Topical 0.1% tacrolimus for the treatment of discoid lupus erythematosus and pemphigus erythematosus in dogs.
Griffies JD; Mendelsohn CL; Rosenkrantz WS; Muse R; Boord MJ; Griffin CE
J Am Anim Hosp Assoc; 2004; 40(1):29-41. PubMed ID: 14736903
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic pemphigus secondary to fludarabine evolving into unusual oral pemphigus vegetans.
Powell AM; Albert S; Oyama N; Sakuma-Oyama Y; Bhogal B; Black MM
J Eur Acad Dermatol Venereol; 2004 May; 18(3):360-4. PubMed ID: 15096157
[TBL] [Abstract][Full Text] [Related]
17. Fatal paraneoplastic pemphigus after removal of Castleman's disease in a child.
Daneshpazhooh M; Moeineddin F; Kiani A; Naraghi ZS; Firooz A; Akhyani M; Chams-Davatchi C
Pediatr Dermatol; 2012; 29(5):656-7. PubMed ID: 22276661
[TBL] [Abstract][Full Text] [Related]
18. Budesonide for local therapy of complex oral mucosal immune-mediated inflammatory diseases: case reports.
Utsman RA; Epstein JB; Elad S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):e11-7. PubMed ID: 18585605
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of the usefulness of mycophenolate mofetil in pemphigus.
Powell AM; Albert S; Al Fares S; Harman KE; Setterfield J; Bhogal B; Black MM
Br J Dermatol; 2003 Jul; 149(1):138-45. PubMed ID: 12890207
[TBL] [Abstract][Full Text] [Related]
20. A case of severe cutaneous and mucosal erosions.
Korbl JD; Brusch A; Lucas M; von Nida J; Wood BA; Leecy TN; Harvey NT
Clin Exp Dermatol; 2020 Aug; 45(6):780-782. PubMed ID: 32410330
[No Abstract] [Full Text] [Related]
[Next] [New Search]
